Payment overview · 2025
General Payments
$27.23
1 reported records · 1 companies
Healthcare provider profile · identity verified
Joshua B Kretchmar, DO
Allopathic & Osteopathic Physicians|Family Medicine · KENT, WA · NPI 1629485701
Verified facts
What the public records show
CMS Open Payments records show Joshua B Kretchmar, DO received $27.23 in general payments during 2025 across 1 reported records.
Teva Pharmaceuticals USA, Inc. accounted for 100.0% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 1 associated product.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Teva Pharmaceuticals USA, Inc. | Unresolved — no canonical attribution shown | $27.23 | 100.0% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $27.23 | 1 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| AUSTEDO XR Normalized: austedo xr |
Drug | Teva Pharmaceuticals USA, Inc. | $27.23 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
No publishable same-company prescribing overlap was found in the loaded Part D year. This does not mean the doctor never prescribed a drug reported elsewhere by a paying company.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 786 | 165 |
| Eliquis | Apixaban | 529 | 68 |
| Levothyroxine Sodium | Levothyroxine Sodium | 505 | 76 |
| Furosemide | Furosemide | 504 | 82 |
| Gabapentin | Gabapentin | 477 | 115 |
| Amlodipine Besylate | Amlodipine Besylate | 474 | 106 |
| Quetiapine Fumarate | Quetiapine Fumarate | 420 | 65 |
| Metoprolol Succinate | Metoprolol Succinate | 365 | 72 |
| Lisinopril | Lisinopril | 336 | 72 |
| Tamsulosin Hcl | Tamsulosin Hcl | 305 | 71 |
| Metformin Hcl | Metformin Hcl | 268 | 48 |
| Potassium Chloride | Potassium Chloride | 262 | 59 |
| Baclofen | Baclofen | 244 | 43 |
| Trazodone Hcl | Trazodone Hcl | 241 | 53 |
| Citalopram Hbr | Citalopram Hydrobromide | 236 | 48 |
| Pantoprazole Sodium | Pantoprazole Sodium | 231 | 60 |
| Losartan Potassium | Losartan Potassium | 228 | 53 |
| Oxycodone Hcl | Oxycodone Hcl | 197 | 53 |
| Metoprolol Tartrate | Metoprolol Tartrate | 187 | 46 |
| Duloxetine Hcl | Duloxetine Hcl | 172 | 44 |
| Xarelto | Rivaroxaban | 169 | 26 |
| Clopidogrel | Clopidogrel Bisulfate | 166 | 35 |
| Jardiance | Empagliflozin | 151 | 24 |
| Mirtazapine | Mirtazapine | 151 | 45 |
| Torsemide | Torsemide | 137 | 32 |
| Carvedilol | Carvedilol | 134 | 33 |
| Sertraline Hcl | Sertraline Hcl | 134 | 35 |
| Divalproex Sodium | Divalproex Sodium | 133 | 24 |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 129 | 38 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 123 | 50 |
| Ondansetron Hcl | Ondansetron Hcl | 121 | 39 |
| Fluoxetine Hcl | Fluoxetine Hcl | 110 | 18 |
| Risperidone | Risperidone | 108 | 15 |
| Latanoprost | Latanoprost | 107 | 26 |
| Levetiracetam | Levetiracetam | 107 | 17 |
| Aripiprazole | Aripiprazole | 106 | 14 |
| Spironolactone | Spironolactone | 106 | 21 |
| Finasteride | Finasteride | 104 | 21 |
| Olanzapine | Olanzapine | 95 | 13 |
| Ondansetron Odt | Ondansetron | 92 | 27 |
| Hydralazine Hcl | Hydralazine Hcl | 90 | 20 |
| Donepezil Hcl | Donepezil Hcl | 88 | 16 |
| Escitalopram Oxalate | Escitalopram Oxalate | 88 | 19 |
| Prednisone | Prednisone | 87 | 24 |
| Buspirone Hcl | Buspirone Hcl | 85 | 19 |
| Montelukast Sodium | Montelukast Sodium | 84 | 11 |
| Allopurinol | Allopurinol | 82 | 16 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 80 | 20 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 77 | 13 |
| Famotidine | Famotidine | 73 | 22 |
| Warfarin Sodium | Warfarin Sodium | 73 | 12 |
| Lantus | Insulin Glargine,hum.Rec.Anlog | 70 | 16 |
| Alendronate Sodium | Alendronate Sodium | 69 | 11 |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 69 | 24 |
| Hydrochlorothiazide | Hydrochlorothiazide | 65 | 14 |
| Lactulose | Lactulose | 61 | 15 |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 60 | 14 |
| Midodrine Hcl | Midodrine Hcl | 60 | 17 |
| Omeprazole | Omeprazole | 57 | 22 |
| Ropinirole Hcl | Ropinirole Hcl | 56 | suppressed |
| Fluticasone Propionate | Fluticasone Propionate | 54 | 27 |
| Haloperidol | Haloperidol | 53 | suppressed |
| Lorazepam | Lorazepam | 53 | 32 |
| Memantine Hcl | Memantine Hcl | 53 | suppressed |
| Metformin Hcl Er | Metformin Hcl | 52 | suppressed |
| Clonazepam | Clonazepam | 51 | 11 |
| Myrbetriq | Mirabegron | 51 | suppressed |
| Lamotrigine | Lamotrigine | 48 | suppressed |
| Insulin Glargine-Yfgn | Insulin Glargine-Yfgn | 47 | 26 |
| Benztropine Mesylate | Benztropine Mesylate | 45 | suppressed |
| Bumetanide | Bumetanide | 44 | suppressed |
| Pravastatin Sodium | Pravastatin Sodium | 43 | suppressed |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 42 | 11 |
| Sucralfate | Sucralfate | 42 | suppressed |
| Januvia | Sitagliptin Phosphate | 40 | suppressed |
| Ezetimibe | Ezetimibe | 38 | suppressed |
| Breo Ellipta | Fluticasone/Vilanterol | 37 | suppressed |
| Diclofenac Sodium | Diclofenac Sodium | 36 | 15 |
| Methocarbamol | Methocarbamol | 35 | 12 |
| Cephalexin | Cephalexin | 34 | 19 |
| Lansoprazole | Lansoprazole | 34 | suppressed |
| Lovastatin | Lovastatin | 34 | suppressed |
| Timolol Maleate | Timolol Maleate | 34 | suppressed |
| Hydrocortisone | Hydrocortisone | 32 | suppressed |
| Insulin Lispro Kwikpen U-100 | Insulin Lispro | 32 | 12 |
| Oxybutynin Chloride | Oxybutynin Chloride | 32 | suppressed |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 30 | 11 |
| Simvastatin | Simvastatin | 30 | suppressed |
| Tramadol Hcl | Tramadol Hcl | 30 | 15 |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 29 | 16 |
| Pregabalin | Pregabalin | 29 | suppressed |
| Brimonidine Tartrate | Brimonidine Tartrate | 28 | suppressed |
| Bupropion Xl | Bupropion Hcl | 28 | suppressed |
| Doxycycline Hyclate | Doxycycline Hyclate | 28 | 19 |
| Lacosamide | Lacosamide | 28 | suppressed |
| Nitroglycerin | Nitroglycerin | 28 | 15 |
| Spiriva Respimat | Tiotropium Bromide | 28 | 11 |
| Humalog | Insulin Lispro | 27 | suppressed |
| Clonidine Hcl | Clonidine Hcl | 26 | suppressed |
| Divalproex Sodium Er | Divalproex Sodium | 26 | suppressed |
| Movantik | Naloxegol Oxalate | 26 | suppressed |
| Oxcarbazepine | Oxcarbazepine | 26 | suppressed |
| Propranolol Hcl | Propranolol Hcl | 26 | suppressed |
| Rivastigmine | Rivastigmine Tartrate | 26 | suppressed |
| Dicyclomine Hcl | Dicyclomine Hcl | 25 | suppressed |
| Doxazosin Mesylate | Doxazosin Mesylate | 25 | suppressed |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 25 | 17 |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 25 | suppressed |
| Ipratropium-Albuterol | Ipratropium/Albuterol Sulfate | 24 | 15 |
| Sevelamer Carbonate | Sevelamer Carbonate | 24 | suppressed |
| Alprazolam | Alprazolam | 23 | suppressed |
| Lubiprostone | Lubiprostone | 23 | suppressed |
| Santyl | Collagenase Clostridium Hist. | 23 | suppressed |
| Acyclovir | Acyclovir | 22 | suppressed |
| Hydromorphone Hcl | Hydromorphone Hcl | 22 | suppressed |
| Methenamine Hippurate | Methenamine Hippurate | 22 | suppressed |
| Morphine Sulfate | Morphine Sulfate | 22 | 14 |
| Morphine Sulfate Er | Morphine Sulfate | 22 | suppressed |
| Sumatriptan Succinate | Sumatriptan Succinate | 22 | suppressed |
| Tizanidine Hcl | Tizanidine Hcl | 22 | suppressed |
| Tradjenta | Linagliptin | 22 | suppressed |
| Albuterol Sulfate | Albuterol Sulfate | 21 | suppressed |
| Amiodarone Hcl | Amiodarone Hcl | 21 | 11 |
| Olanzapine Odt | Olanzapine | 21 | suppressed |
| Ziprasidone Hcl | Ziprasidone Hcl | 21 | suppressed |
| Alcohol Prep Pads | Alcohol Antiseptic Pads | 20 | suppressed |
| Atropine Sulfate | Atropine Sulfate | 20 | 18 |
| Calcium Acetate | Calcium Acetate | 20 | suppressed |
| Fentanyl | Fentanyl | 20 | suppressed |
| Insulin Lispro | Insulin Lispro | 20 | 12 |
| Nystatin | Nystatin | 20 | suppressed |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 20 | suppressed |
| Ozempic | Semaglutide | 20 | suppressed |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 20 | suppressed |
| Spiriva Handihaler | Tiotropium Bromide | 20 | suppressed |
| Dapagliflozin | Dapagliflozin Propanediol | 19 | suppressed |
| Glipizide Er | Glipizide | 19 | suppressed |
| Isosorbide Dinitrate | Isosorbide Dinitrate | 19 | suppressed |
| Meloxicam | Meloxicam | 19 | suppressed |
| Trulicity | Dulaglutide | 19 | suppressed |
| Zonisamide | Zonisamide | 19 | suppressed |
| Amitriptyline Hcl | Amitriptyline Hcl | 18 | suppressed |
| Dorzolamide-Timolol | Dorzolamide Hcl/Timolol Maleat | 17 | suppressed |
| Entresto | Sacubitril/Valsartan | 17 | suppressed |
| Acetazolamide | Acetazolamide | 16 | suppressed |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 16 | suppressed |
| Meclizine Hcl | Meclizine Hcl | 16 | suppressed |
| Symbicort | Budesonide/Formoterol Fumarate | 16 | suppressed |
| Estradiol | Estradiol | 15 | suppressed |
| Glipizide | Glipizide | 15 | suppressed |
| Humalog Kwikpen U-100 | Insulin Lispro | 15 | suppressed |
| Mupirocin | Mupirocin | 15 | suppressed |
| Nortriptyline Hcl | Nortriptyline Hcl | 15 | suppressed |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 15 | 12 |
| Xtampza Er | Oxycodone Myristate | 15 | suppressed |
| Chlorhexidine Gluconate | Chlorhexidine Gluconate | 14 | suppressed |
| Digoxin | Digoxin | 14 | suppressed |
| Humulin N Kwikpen | Insulin Nph Human Isophane | 14 | suppressed |
| Labetalol Hcl | Labetalol Hcl | 14 | suppressed |
| Promethazine Hcl | Promethazine Hcl | 14 | suppressed |
| Brilinta | Ticagrelor | 13 | suppressed |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 13 | suppressed |
| Levofloxacin | Levofloxacin | 13 | suppressed |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 13 | suppressed |
| Metoclopramide Hcl | Metoclopramide Hcl | 13 | suppressed |
| Nifedipine Er | Nifedipine | 13 | suppressed |
| Nitrofurantoin | Nitrofurantoin Macrocrystal | 13 | suppressed |
| Rybelsus | Semaglutide | 13 | suppressed |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 13 | suppressed |
| Topiramate | Topiramate | 13 | suppressed |
| Ultra-Fine Mini Pen Needle | Pen Needle, Diabetic | 13 | suppressed |
| Colesevelam Hcl | Colesevelam Hcl | 12 | suppressed |
| Insulin Lispro Protamine Mix | Insulin Lispro Protamin/Lispro | 12 | suppressed |
| Letrozole | Letrozole | 12 | suppressed |
| Levocarnitine | Levocarnitine | 12 | suppressed |
| Loperamide | Loperamide Hcl | 12 | 11 |
| Memantine Hcl Er | Memantine Hcl | 12 | suppressed |
| Trospium Chloride | Trospium Chloride | 12 | suppressed |
| Azithromycin | Azithromycin | 11 | suppressed |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 11 | suppressed |
| Bupropion Hcl | Bupropion Hcl | 11 | suppressed |
| Chlorpromazine Hcl | Chlorpromazine Hcl | 11 | suppressed |
| Chlorthalidone | Chlorthalidone | 11 | suppressed |
| Doxycycline Monohydrate | Doxycycline Monohydrate | 11 | suppressed |
| Flecainide Acetate | Flecainide Acetate | 11 | suppressed |
| Sulfasalazine Dr | Sulfasalazine | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $27.23 · 1 records | Teva Pharmaceuticals USA, Inc. | AUSTEDO XR | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error